Forte Biosciences, Inc. - 8-K Filing
Forte Biosciences agreed to be acquired by argenx BV in a $77/share cash deal via tender offer followed by merger (Items: 1.01 Entry into a Material Definitive Agreement, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $FBRX